Anne B. Chang at Charles Darwin University - Research Interests, Publications & Academic Profile

Anne B. Chang

Charles Darwin University

Australia

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Chinese students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pediatric Nursing

50%

Pharmacotherapy

20%

Pediatric

50%

Respiratory Medicine

50%

Lung Disease

50%

Bronchoscopy

40%

Cystic Fibrosis Research

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles11

The Economic Burden of Bronchiectasis

Article Link

Year:

2023

Cough Hypersensitivity Syndrome: Why Its Use Is Inappropriate in Children

Article Link

Year:

2023

An Automated Broncho-Arterial (BA) Pair Segmentation Process and Assessment of BA Ratios in Children with Bronchiectasis Using Lung HRCT Scans: A Pilot Study

Article Link

Year:

2023

Extracellular traps are evident in Romanowsky-stained smears of bronchoalveolar lavage from children with non-cystic fibrosis bronchiectasis.

Article Link

Year:

2023

Phenotypic Features of Pediatric Bronchiectasis Exacerbations Associated With Symptom Resolution After 14 Days of Oral Antibiotic Treatment

Article Link

Year:

2023

Does routine spirometry impact on clinical decisions and patient-related outcome measures of children seen in respiratory clinics: an open-label randomised controlled trial

Article Link

Year:

2023

Thoracic Society of Australia and New Zealand (TSANZ) position statement on chronic suppurative lung disease and bronchiectasis in children, adolescents and adults in Australia and New Zealand

Article Link

Year:

2023

'Teach me how to look after myself': What people with bronchiectasis want from education in a pulmonary rehabilitation setting

Article Link

Year:

2023

Balancing the medical and social needs of children during the COVID-19 pandemic

Article Link

Year:

2023

Extended Versus Standard Antibiotic Course Duration in Children <5 Years of Age Hospitalized With Community-acquired Pneumonia in High-risk Settings: Four-week Outcomes of a Multicenter, Double-blind, Parallel, Superiority Randomized Controlled Trial

Article Link

Year:

2022

European Respiratory Society statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials

Article Link

Year:

2022

Collaborators10

Sami Azam

Charles Darwin University

AUSTRALIA

Robyn L. Marsh

Charles Darwin University

AUSTRALIA

Jack Roberts

Queensland University of Technology

AUSTRALIA

Paul King

MONASH UNIVERSITY

AUSTRALIA

Emma Kennedy

Flinders University

AUSTRALIA

Friso De Boer

Charles Darwin University

AUSTRALIA

Sheikh Mohammed Shariful Islam

Deakin University

AUSTRALIA

Sanjeewa Kularatna

Queensland University of Technology

AUSTRALIA

Victor Oguoma

AUSTRALIA

Julie Marchant

Associate Professor

Queensland University of Technology

AUSTRALIA

How do Chinese students reach out?

Meet Kite AI

Anne B. Chang

How do Chinese students reach out?

Contact this professor

Research Interests

Ask ApplyKite AI

Articles11

The Economic Burden of Bronchiectasis

Cough Hypersensitivity Syndrome: Why Its Use Is Inappropriate in Children

An Automated Broncho-Arterial (BA) Pair Segmentation Process and Assessment of BA Ratios in Children with Bronchiectasis Using Lung HRCT Scans: A Pilot Study

Extracellular traps are evident in Romanowsky-stained smears of bronchoalveolar lavage from children with non-cystic fibrosis bronchiectasis.

Phenotypic Features of Pediatric Bronchiectasis Exacerbations Associated With Symptom Resolution After 14 Days of Oral Antibiotic Treatment

Does routine spirometry impact on clinical decisions and patient-related outcome measures of children seen in respiratory clinics: an open-label randomised controlled trial

Thoracic Society of Australia and New Zealand (TSANZ) position statement on chronic suppurative lung disease and bronchiectasis in children, adolescents and adults in Australia and New Zealand

'Teach me how to look after myself': What people with bronchiectasis want from education in a pulmonary rehabilitation setting

Balancing the medical and social needs of children during the COVID-19 pandemic

Extended Versus Standard Antibiotic Course Duration in Children &lt;5 Years of Age Hospitalized With Community-acquired Pneumonia in High-risk Settings: Four-week Outcomes of a Multicenter, Double-blind, Parallel, Superiority Randomized Controlled Trial

European Respiratory Society statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials

Collaborators10

Sami Azam

Robyn L. Marsh

Jack Roberts

Paul King

Emma Kennedy

Friso De Boer

Sheikh Mohammed Shariful Islam

Sanjeewa Kularatna

Victor Oguoma

Julie Marchant

How do Chinese students reach out?

Extended Versus Standard Antibiotic Course Duration in Children <5 Years of Age Hospitalized With Community-acquired Pneumonia in High-risk Settings: Four-week Outcomes of a Multicenter, Double-blind, Parallel, Superiority Randomized Controlled Trial